Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes

Timely diagnosis of type 1 diabetes (T1D), especially in high-risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases, having either those diseases or a family history of them will represent a risk of T1D. From a search of the literature conducted in August 2024, we review here the evidence for the risk of either T1D or the development of T1D in association with other autoimmune diseases or a family history of those diseases. Increased risk of subsequent T1D development was identified for individuals with autoimmune diseases, including coeliac disease, autoimmune thyroid disease, autoimmune Addison's disease, juvenile idiopathic arthritis, primary biliary cholangitis, ulcerative colitis, vitiligo, and myasthenia gravis. Increased prevalence of diabetes-associated autoantibody positivity was found among non-diabetic individuals with coeliac and autoimmune thyroid diseases compared with individuals without these autoimmune diseases. Increased risk of T1D was also found for individuals with a family history of autoimmune diseases, including coeliac disease, thyroid disease, Addison's disease, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, autoimmune liver disease, pernicious anaemia, inflammatory bowel disease, multiple sclerosis, and granulomatosis with polyangiitis. This review highlights how certain individuals at risk of T1D can be identified to offer them islet autoantibody screening and, thereby, early detection of T1D.

Authors

Institutions

Publication Details

Journal
Diabetes/Metabolism Research and Reviews
Published
2025-12-02
DOI
https://doi.org/10.1002/dmrr.70110
Primary Topic
Celiac Disease Research and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes

Richard A. Oram, Dimitrios Chantzichristos, Richard David Leslie, Daniel Agardh et al.
Diabetes/Metabolism Research and Reviews
Celiac Disease Research and Management
article

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes

Richard A. Oram, Dimitrios Chantzichristos, Richard David Leslie, Daniel Agardh, Arunjot Singh, Marian Rewers, Bijay Vaidya, Nicholas J. Thomas, Dana Dabelea
article en

Abstract

Timely diagnosis of type 1 diabetes (T1D), especially in high-risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases, having either those diseases or a family history of them will represent a risk of T1D. From a search of the literature conducted in August 2024, we review here the evidence for the risk of either T1D or the development of T1D in association with other autoimmune diseases or a family history of those diseases. Increased risk of subsequent T1D development was identified for individuals with autoimmune diseases, including coeliac disease, autoimmune thyroid disease, autoimmune Addison's disease, juvenile idiopathic arthritis, primary biliary cholangitis, ulcerative colitis, vitiligo, and myasthenia gravis. Increased prevalence of diabetes-associated autoantibody positivity was found among non-diabetic individuals with coeliac and autoimmune thyroid diseases compared with individuals without these autoimmune diseases. Increased risk of T1D was also found for individuals with a family history of autoimmune diseases, including coeliac disease, thyroid disease, Addison's disease, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, autoimmune liver disease, pernicious anaemia, inflammatory bowel disease, multiple sclerosis, and granulomatosis with polyangiitis. This review highlights how certain individuals at risk of T1D can be identified to offer them islet autoantibody screening and, thereby, early detection of T1D.

Diabetes/Metabolism Research and ReviewsVol. 42(1)
Children's Hospital of Philadelphia (US), Queen Mary University of London (GB), Lund University (SE), University of Exeter (GB), Sahlgrenska University Hospital (SE), Royal Devon and Exeter Hospital (GB), University of Colorado Anschutz Medical Campus (US), University of Pennsylvania (US), University of Gothenburg (SE)
Sanofi
Openalex Percentile: Top 47%
Celiac Disease Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.